Extensions

For US Patent 10796296, here's a detailed breakdown of its patent term, related applications, and projected expiration:

Patent Term Adjustments (PTA)

Patent Term Adjustment (PTA) is granted to compensate patent applicants for certain delays caused by the USPTO during the prosecution of a utility or plant patent application. These delays can include the USPTO failing to:

• Issue an office action within 14 months of the application filing.
• Respond to a reply or appeal within four months.
• Act on an application within four months after a decision by the Patent Trial and Appeal Board (PTAB) or a federal court.
• Issue a patent within four months after payment of the issue fee.
• Issue a patent within 36 months from the filing date of an application.

The official PTA calculation is determined by a computer program at the time the patent issues and is included in the Issue Notification Letter. Any request for reconsideration of the PTA calculation must be made within two months of the patent issuance.

To determine the specific PTA for US10796296, direct access to the patent's prosecution history in the USPTO Patent Center is required. Without this, the exact number of days of PTA cannot be definitively stated.

Patent Term Extensions (PTE)

Patent Term Extension (PTE) is available under the Hatch-Waxman Act (35 U.S.C. § 156) for patents claiming products that require regulatory approval (e.g., human drugs, medical devices, food additives) before commercial marketing or use. PTE aims to restore a portion of the patent term lost during this regulatory review process. The extension is limited to a maximum of five years, and the total patent life with a PTE cannot exceed 14 years from the date of FDA approval.

US10796296, titled "Kit, system and associated method and service for providing a platform to prevent fraudulent financial transactions," describes a system for financial transactions, not a product requiring regulatory approval from agencies like the FDA. Therefore, it is highly unlikely to be eligible for Patent Term Extension (PTE) under 35 U.S.C. § 156.

Continuation and Divisional Applications

• Continuation Applications: US10796296 is a continuation of U.S. patent application Ser. No. 15/786,470, filed Oct. 17, 2017, which is a continuation-in-part of U.S. patent application Ser. No. 14/691,499, filed Apr. 20, 2015 (now abandoned), which is a continuation of U.S. patent application Ser. No. 13/974,837, filed Aug. 23, 2013 (now abandoned), which is a continuation-in-part of U.S. patent application Ser. No. 13/185,432, filed Jul. 18, 2011 (now U.S. Pat. No. 8,554,671). The patent explicitly states that it includes "the same subject matter as U.S. patent application Ser. No. 13/185,432, and is effectively a continuation thereof." [cite: Full patent text]
• Divisional Applications: A divisional application is filed to pursue a "separate invention" that was not chosen in the parent application due to a restriction requirement by the USPTO. The patent does not explicitly state that US10796296 is a divisional application. However, a continuation application can be designated a divisional application up to the grant of the patent. Without reviewing the prosecution history, it cannot be definitively stated whether any specific divisional applications were filed from its parent applications.

Related Family Members

The patent family for US10796296 includes:

• U.S. Patent No. 8,554,671 (parent application Ser. No. 13/185,432) [cite: Full patent text]
• U.S. patent application Ser. No. 13/974,837 (abandoned) [cite: Full patent text]
• U.S. patent application Ser. No. 14/691,499 (abandoned) [cite: Full patent text]
• U.S. patent application Ser. No. 15/786,470 [cite: Full patent text]
• US Patent No. 10,937,018 [cite: Litigation summary]
• US Patent No. 11,087,307 [cite: Litigation summary]
• US Patent No. 12,014,347 [cite: Litigation summary]

Projected Expiration Date

The standard term of a U.S. utility patent (other than a design patent) issued from an application filed on or after June 8, 1995, is 20 years from the earliest filing date for which a benefit is claimed. This date is subject to any Patent Term Adjustments (PTA) or deductions for applicant delay.

US10796296 claims priority back to U.S. patent application Ser. No. 13/185,432, which has a filing date of July 18, 2011. [cite: Full patent text]

Therefore, the baseline expiration date, without considering any PTA, would be 20 years from July 18, 2011, which is July 18, 2031.

However, the legal status information on Google Patents for US10796296 lists the "Anticipated expiration" as 2031-07-18. [cite: Full patent text] This indicates that either there was no PTA granted, or any granted PTA was offset by applicant delay, resulting in the expiration date aligning with the 20-year term from the earliest priority date.

To confirm the exact expiration date and any PTA, a review of the official USPTO prosecution history for US10796296 would be necessary.